Private Equity Geneva: Top Firms in 2026

Key Facts: Geneva's Private Equity Ecosystem

• Geneva hosts more than 20 dedicated PE firms and PE-affiliated managers, with 75+ VC and PE investors identified across the broader Swiss ecosystem.
• Aggregate AUM exceeds CHF 1 trillion when major private banking groups are included. Pure-play PE funds typically range from €500M to €2B in fund size.
• Deal sizes span a wide spectrum: €40M–€80M for secondary PE transactions, €30M–€300M enterprise value for mid-market buyout, and $3M–$20M initial allocation for MedTech growth equity.
• Geneva leads Switzerland in private banking-affiliated PE and independent boutiques, including Pictet, Lombard Odier, Edmond de Rothschild, Unigestion, and ACE & Company.
• ESG integration runs deep across the Geneva ecosystem. Edmond de Rothschild reports 82% of its €4.3B PE assets in high-intentionality responsible or sustainable strategies.
• Unigestion's Secondary Fund VI (USEC VI) closed at a hard cap of €1.7B ($2B) in November 2025, oversubscribed, signalling sustained LP demand for Swiss-managed secondaries.
• Switzerland's political stability, FINMA regulatory framework, attractive tax environment, and central European location make Geneva a preferred base for global PE capital deployment.

Private Equity in Geneva: Market Overview

Geneva's private equity firms operate within a structurally distinct ecosystem found nowhere else in Europe. The city combines private banking-affiliated fund managers, independent boutiques, secondary PE specialists, and fund-of-funds platforms. All operate within one of the world's most stable regulatory environments. The Swiss Financial Market Supervisory Authority (FINMA) governs fund structures and manager licensing. LP communities consistently rank this oversight as a key confidence factor.

The city's wealth management heritage directly shapes how deal flow reaches fund managers here. Geneva's family offices and high-net-worth investors co-invest alongside PE general partners (GPs) at higher rates than in comparable markets. Pictet has offered co-investment access since 1989, and Manixer explicitly serves family office advisory mandates. The proximity of international organizations, including the UN, WHO, and World Economic Forum, creates a concentrated network of institutional investors and sovereign-adjacent limited partners (LPs). Few other European cities offer comparable LP access.

Switzerland manages approximately CHF 360 billion in private markets assets, with private equity accounting for CHF 260 billion of that total. Geneva accounts for the largest share of the Swiss PE ecosystem, with 20+ dedicated managers versus 15 in Zurich and three in Baar/Zug. The distinction matters. Geneva specialises in private banking-affiliated PE and Romandy boutiques. Zurich hosts larger asset management platforms including EFG and Amundi Alpha Associates. Baar/Zug is home to Partners Group (EUR 127B AUM), the largest Swiss pure-play PE firm by any measure.

Firm Comparison at a Glance

The following table covers the primary PE and PE-affiliated managers active in or closely associated with Geneva and broader Switzerland, ranked by AUM where data is available.

Geneva's largest players by dedicated PE AUM are Edmond de Rothschild (€4.3B) and Unigestion (CHF 22.7B). Pictet's private banking scale gives it the most co-investment deal flow of any Geneva-headquartered manager.

Top Picks by Investment Strategy

Largest Geneva-Based AUM: Pictet Group manages CHF 698B across its private banking platform. Its PE division has been active in co-investments since 1989, with direct investments in European mid-market business services, education, and industrials.

Secondary PE Leader: Unigestion closed its USEC VI fund at a hard cap of €1.7B in November 2025, oversubscribed, confirming its position as Geneva's most prominent dedicated secondaries manager. Its ESG integration spans more than 20 years of formal practice.

Healthcare and Life Sciences Specialist: ArchiMed is the strongest healthcare-only PE manager in the Swiss ecosystem. Its aggregate value creation exceeds €10B, with top-decile internal rate of return (IRR) performance across multiple vintage years.

Top Mid-Market Buyout: Capvis has deployed several billion euros building niche champions across industrial technology, software, and advanced services in German-speaking Europe. It targets companies with enterprise values of €30M–€300M through majority control and succession deals.

Impact and Responsible Investing Leader: Edmond de Rothschild reports 82% of its €4.3B PE assets in high-intentionality responsible, sustainable, or impact strategies, covering energy transition, emerging economies, and human capital themes.

Most Active GP-Led Secondaries Platform: Montana Capital Partners has completed 100+ secondary transactions since 2011. The firm specialises in LP stake purchases and GP-led continuation vehicles at deal sizes of €40M–€80M across European and North American mid-market funds.

Broadest Multi-Stage Access: ACE & Company manages USD 1.9B across secondaries, buyout, and venture strategies, covering more than 20 sectors. Recent activity includes the $6M Veezoo Series A in September 2025.

Top Geneva PE Firms in Detail

Pictet Group

Pictet's PE division operates from a platform managing CHF 698B, with a co-investment programme active since 1989, longer than most dedicated PE boutiques have existed. The firm pursues a multi-manager approach combining primary fund commitments, co-investments, thematic strategies, and direct European mid-market investments in business services, education, and industrials. Its scale translates directly into access: Pictet's LP relationships span global top-tier general partners, giving co-investors proprietary deal flow that independent managers cannot replicate. Institutional LPs seeking diversified European PE exposure through a platform with deep GP network access will find Pictet the most established entry point in Geneva.

Edmond de Rothschild Group

Edmond de Rothschild's PE unit manages €4.3B across 11 investment strategies, making it one of Europe's most distinctive impact-oriented platforms. Eighty-two percent of that capital sits in high-intentionality responsible, sustainable, or impact strategies, covering energy transition, resource efficiency, and human capital themes. The firm runs buyout and growth capital mandates for European SMEs alongside emerging economy allocations, with a particular focus on African infrastructure that no other Geneva-based manager addresses at comparable scale. LPs seeking measurable ESG outcomes alongside financial returns will find Edmond de Rothschild's reporting framework and strategy depth go beyond marketing-level commitments.

Lombard Odier Group

Sustainable investing is not a product sleeve at Lombard Odier: it is the firm's stated core strategy, differentiating it from Geneva peers that treat ESG as an overlay. Managing CHF 200B+ across the group, its PE activity concentrates on renewable energy, fintech, healthcare, and digital transformation companies. The family-owned partnership structure, stretching back to 1796, creates a long-term capital orientation that aligns naturally with PE hold periods of three to seven years. Growth equity and buyout allocations are screened against the firm's sustainability framework, making it a primary destination for European pension funds and sovereign wealth LPs with binding sustainability mandates.

Unigestion

Unigestion's November 2025 close of Secondary Fund VI at its hard cap of €1.7B, oversubscribed, is the clearest recent signal of LP confidence in a Geneva-managed PE platform. The firm has formally integrated ESG criteria into its investment process for more than 20 years. Institutional investors can verify this against actual vintage year performance rather than pledges. Managing CHF 22.7B across private equity, equities, and multi-asset strategies, the firm runs both a small and mid-market primaries programme alongside its well-known secondaries capability. LPs seeking top-decile secondary PE returns from a long-standing Swiss independent manager will find Unigestion the most credible option in the Geneva market.

ACE & Company

The breadth of ACE & Company's mandate sets it apart from every other Geneva-based PE manager. The firm deploys USD 1.9B across three distinct strategies: secondaries, buyouts, and early-stage ventures spanning more than 20 sectors. ACE Ventures backed Veezoo's $6M Series A in September 2025. ACE Buyout joined Trimountain Partners in backing ABCA in July 2025. Both deals demonstrate active deployment across the full risk spectrum. Family offices and high-net-worth investors seeking customised exposure to multiple PE stages through a single Geneva relationship will find ACE & Company the most flexible platform available.

Montana Capital Partners

Montana Capital Partners is the most focused secondary PE specialist in the Swiss market. The firm has completed more than 100 transactions since 2011, operating exclusively in secondary PE through LP stake purchases and GP-led continuation vehicles across European and North American mid-market funds. It is FINMA-regulated, typically targets deal sizes of €40M–€80M, and has closed multiple funds at hard caps, demonstrating consistent capacity discipline. Institutional LPs seeking a pure secondary PE allocation without strategy drift will find Montana Capital Partners their primary Swiss option. Sellers of LP interests seeking bespoke liquidity solutions benefit from the firm's GP relationships, numbering in the hundreds.

ArchiMed

No PE manager operating from Switzerland invests as exclusively or as deeply in healthcare as ArchiMed. The firm covers the full spectrum, from biopharma, medtech, diagnostics, and healthcare IT to consumer health. Investment sizes range from €10M to €1B, depending on company maturity and transaction type. Aggregate value creation across its portfolio exceeds €10B, with vintage year performance consistently in the top decile relative to comparable healthcare PE funds. Founders of post-clinical medtech companies with FDA clearance and validated commercial traction will find ArchiMed's sector depth and operator network purpose-built for their stage. No other Geneva-adjacent PE manager combines this level of healthcare exclusivity with that demonstrated scale of returns.

Capvis

Capvis has spent more than three decades building niche champions in the German-speaking European mid-market. It is the most experienced Swiss-based buyout manager across industrial technology, advanced services, healthcare, software, and manufacturing. The firm targets companies with enterprise values between €30M and €300M, typically seeking majority control positions, succession opportunities, or spinouts where management continuity is central to the thesis. Several billion euros have been deployed across dozens of transactions. Swiss and German-speaking European business owners planning ownership transitions will find Capvis the most experienced execution partner in the region. Corporate groups seeking buyers for non-core subsidiaries in that size range benefit equally.

Hermance Capital Partners

Hermance Capital Partners provides access to globally diversified private equity through a CHF 1B boutique that combines primary fund investments, secondary PE fund allocations, and co-investments. The firm invests across North American and European funds, covering industrials, consumer goods, technology, and healthcare without single-sector concentration risk. Its scale positions it between the multi-billion private banking platforms and single-strategy specialists. This makes it particularly suited to family offices and smaller institutional LPs seeking managed, diversified PE exposure. Minimum commitment thresholds are significantly lower than those of the largest fund-of-funds managers, and co-investment access provides return enhancement without proportional fee drag.

Manixer

Manixer's record of exits into globally recognised buyers distinguishes it from other Geneva direct PE platforms. Portfolio company Orbitera was acquired by Google in 2016. Bellevue Education sold to GEMS Education, the world's largest K-12 operator, in 2018. Solasa Group exited to Schulthess Maschinen AG in 2023. Current holdings include Dina, a Swiss IT services company serving mid-market corporates and public sector clients with more than 200 permanent staff. Manixer focuses exclusively on Swiss companies with positive EBITDA, proven management teams, and understandable business models, avoiding startups, turnarounds, and loss-making businesses. Family offices seeking advisory services on direct Swiss PE investments or high-yielding real estate portfolios engage Manixer for both sourcing and portfolio monitoring.

Investment Trends Shaping Geneva PE

Secondary PE and Liquidity Solutions

Interest rate normalisation since 2023 has accelerated secondary market activity as LPs in older vintage funds seek liquidity before traditional exit windows open. Unigestion's USEC VI oversubscription at €1.7B in November 2025 reflects strong institutional demand for managed secondary exposure. Montana Capital Partners expanded its GP-led continuation vehicle activity over the same period, completing transactions with hundreds of general partner counterparties across Europe and North America.

Healthcare and MedTech Consolidation

ArchiMed continues deploying capital across biopharma, medtech, diagnostics, and healthcare IT at deal sizes ranging from €10M to €1B. Post-clinical MedTech companies with FDA clearance and early revenue attract particular attention, given the de-risked profile they present relative to pre-approval assets. This consolidation wave rewards specialists with deep healthcare networks over generalist buyout funds entering the sector opportunistically.

Energy Transition and Sustainable Finance

Lombard Odier and Edmond de Rothschild lead the Geneva market in energy transition capital deployment. Edmond de Rothschild's infrastructure and impact strategies cover low-carbon mobility, renewable energy assets, and ecosystem protection. ESG integration has moved from voluntary to structurally embedded across the Swiss PE ecosystem. LPs from European pension funds and sovereign wealth funds now require it as a baseline condition rather than a differentiator.

European Mid-Market Buyout and Succession Deals

Succession transactions remain a persistent source of deal flow across German-speaking Switzerland and the broader DACH market. Capvis actively pursues majority control positions in family-owned businesses where founders are transitioning ownership, targeting enterprise values of €30M–€300M in industrial technology and advanced services. Manixer applies an equivalent strategy to smaller Swiss companies, focusing on EBITDA-positive businesses with strong management and scalable models.

Digital Infrastructure and Fintech

SYZ Group and Reyl & Cie are the most active Geneva-based investors in growth-stage fintech and digital infrastructure. Pictet's direct investment arm has backed digital transformation companies in the European mid-market, while ACE Ventures deployed capital into AI-enabled technology companies including Veezoo's $6M Series A in September 2025. Moderating inflation and central bank easing since 2024 have improved deal valuations and expanded uncommitted capital available for deployment across these sectors.

How to Evaluate PE Investors in This Market

FINMA regulatory standing is the first verification point for any LP evaluating a Swiss-domiciled fund. Montana Capital Partners is explicitly FINMA-regulated. Most Geneva-based managers operating PE fund structures require FINMA licensing under the Swiss Federal Act on Collective Investment Schemes. Absence of FINMA authorisation for a Swiss-domiciled fund warrants immediate clarification before any engagement proceeds.

Sector specialisation depth determines return potential in ways that AUM figures alone do not capture. ArchiMed's healthcare-only mandate produces a deal sourcing network and due diligence capability that a diversified manager cannot replicate. Capvis's German-speaking European industrial focus provides pricing and execution advantages unavailable to sector-agnostic competitors. Request vintage year performance by strategy, not just aggregate returns, to assess whether specialisation translates into measurable outperformance.

Fund size must align with a firm's target deal size to avoid capacity constraints. A CHF 1B boutique like Hermance Capital Partners operates at a fundamentally different scale than Pictet's multi-hundred-billion platform. Neither is superior, but each serves different mandate sizes and co-investment thresholds. The ratio of GP commitment to total fund size provides an alignment signal. Hard cap discipline, as demonstrated by Unigestion's USEC VI close, indicates a manager prioritising returns over fee income.

Independent boutiques and bank-affiliated managers present different conflict of interest profiles. A firm embedded in a private banking group may face competing incentives between wealth management client relationships and PE investment decisions. Review whether the PE unit operates with separate investment committees and independent governance from the parent bank's advisory business.

Co-investment rights are increasingly important to LP economics. Pictet has offered co-investment access since 1989. ACE & Company and Hermance Capital Partners both offer structured co-investment alongside fund commitments. Securing co-investment rights reduces average fee drag across the full PE allocation, improving net-of-fee IRR over the life of the programme.

Which Firm Fits Your Needs?

Healthcare founders with FDA-cleared products and revenues above $1M ARR should prioritise ArchiMed for its sector depth and €10B+ value creation track record. Earlier-stage post-clinical MedTech companies can consider Geneva PE platforms investing at the $3M–$20M initial range. Founders in European mid-market industrials or advanced services with positive EBITDA and enterprise values between €30M and €300M will find Capvis the most experienced buyer in the German-speaking region. Technology and fintech companies at growth stage have active investors in SYZ Group, Reyl & Cie, and ACE Ventures. All three operate from Geneva with sector-specific portfolio networks.

Institutional LPs building diversified PE programmes should start with Unigestion for secondaries and primaries exposure. The oversubscribed USEC VI close in 2025 provides tangible evidence of LP demand. Hermance Capital Partners offers globally diversified fund-of-funds plus co-investment access at CHF 1B scale. Its minimum commitment thresholds are lower than those of the major private banking platforms. BCGE Asset Management provides a fund-of-funds approach active since 2010, targeting best-in-class PE managers across primary and secondary strategies.

Family offices and high-net-worth individuals seeking direct PE relationships will find the most tailored service at Manixer. The firm provides direct investment opportunities in Swiss companies and advisory services on existing portfolios. Moravia Capital handles bespoke private markets mandates at €50M–€500M with customised fund-of-funds, co-investment, and direct PE structuring. ACE & Company's multi-stage model accommodates family office investors across the full PE risk spectrum without requiring separate manager relationships for each strategy. For impact-focused allocators, Edmond de Rothschild's 82% high-intentionality AUM and structured sustainability reporting make it the most credible Geneva-based choice.

Methodology

This guide to Geneva private equity firms was compiled using PE industry databases, firm websites, press releases, and publicly disclosed fund information as of 2025–2026. Firm identification drew on a universe of 75 VC and PE investors in Geneva sourced from industry platforms, supplemented by firm-level disclosures and direct research into fund closes, AUM figures, and notable transactions. Selection required a Geneva or Swiss headquarters, an active PE or alternatives investment mandate, and at least one verifiable AUM figure or completed fund activity. AUM figures are presented as reported by each firm; where not publicly available, they are listed as undisclosed rather than estimated. Managers are not ranked solely by AUM: editorial judgment incorporates strategy depth, vintage year track record, and relevance to the specific reader profiles addressed in this guide. The most recent data point referenced is Unigestion's USEC VI fund close in November 2025. Manixer exit data reflects transactions through October 2023.